Literature DB >> 21767639

Differential effects of insulin on peripheral diabetes-related changes in mitochondrial bioenergetics: involvement of advanced glycosylated end products.

Aline Pertile Remor1, Filipe José de Matos, Karina Ghisoni, Thiago Lenoir da Silva, Greici Eidt, Marília Búrigo, Andreza Fabro de Bem, Paulo César Lock Silveira, Andrés de León, Maria Cecilia Sanchez, Alexandre Hohl, Viviane Glaser, Carlos-Alberto Gonçalves, André Quincozes-Santos, Rafael Borba Rosa, Alexandra Latini.   

Abstract

Large scale clinical trials have demonstrated that an intensive antihyperglycemic treatment in diabetes mellitus (DM) in individuals reduces the incidence of micro- and macrovascular complications, e.g. nephropathy, retinopathy, DM-accelerated atherosclerosis, myocardial infarction, or limb amputations. Here, we investigated the effect of short- and long-term insulin administration on mitochondrial function in peripheral tissues of streptozotocin (STZ)-induced hyperglycemic rats. In addition, the in vitro effect of methylglyoxal (MG), advanced glycation end products (AGEs) and human diabetic plasma on mitochondrial activity was investigated in skeletal muscle and liver mitochondria and in rat skin primary fibroblasts. Hyperglycemic STZ rats showed tissue-specific patterns of energy deficiency, evidenced by reduced activities of complexes I, II and/or IV after 30 days of hyperglycemia in heart, skeletal muscle and liver; moreover, cardiac tissue was found to be the most sensitive to the diabetic condition, since energy metabolism was impaired after 10 days of the hyperglycemia. Insulin-induced tight glycemic control was effective in protecting against the hyperglycemia-induced inhibition of mitochondrial enzyme activities. Furthermore, the long-term hormone replacement (30 days) also increased these activities in kidney from STZ-treated animals, where the hyperglycemic state did not modify the electron transport activity. Results from in vitro experiments indicate that mitochondrial impairment could result from oxidative stress-induced accumulation of MG and/or AGEs. Further investigations demonstrated that human plasma AGE accumulation elicits reduced mitochondrial function in skin fibroblast. These data suggest that persistent hyperglycemia results in tissue-specific patterns of energy deficiency and that early and continuous insulin therapy is necessary to maintain proper mitochondrial metabolism. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767639     DOI: 10.1016/j.bbadis.2011.06.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  Mitochondria as a target of cardioprotection in models of preconditioning.

Authors:  Magdaléna Jašová; Ivana Kancirová; Iveta Waczulíková; Miroslav Ferko
Journal:  J Bioenerg Biomembr       Date:  2017-07-20       Impact factor: 2.945

Review 2.  Mitochondrial Defects Drive Degenerative Retinal Diseases.

Authors:  Deborah A Ferrington; Cody R Fisher; Renu A Kowluru
Journal:  Trends Mol Med       Date:  2019-11-23       Impact factor: 11.951

3.  Mitochondrial dysfunction and its impact on diabetic heart.

Authors:  Suresh Kumar Verma; Venkata Naga Srikanth Garikipati; Raj Kishore
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-09-01       Impact factor: 5.187

4.  1,25(OH)2 vitamin D3 signalling on immature rat Sertoli cells: gamma-glutamyl transpeptidase and glucose metabolism.

Authors:  Renata Gonçalves; Ariane Zamoner; Leila Zanatta; Ana Paula Zanatta; Aline Pertile Remor; Débora da Luz Scheffer; Alexandra Latini; Fátima Regina Mena Barreto Silva
Journal:  J Cell Commun Signal       Date:  2017-02-03       Impact factor: 5.782

Review 5.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

6.  miR-192 is upregulated in T1DM, regulates pancreatic β-cell development and inhibits insulin secretion through suppressing GLP-1 expression.

Authors:  Wen Pan; Yanan Zhang; Chun Zeng; Fen Xu; Jinhua Yan; Jianping Weng
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

7.  Increased erythrocytes by-products of arginine catabolism are associated with hyperglycemia and could be involved in the pathogenesis of type 2 diabetes mellitus.

Authors:  Serafín Ramírez-Zamora; Miguel L Méndez-Rodríguez; Marisela Olguín-Martínez; Lourdes Sánchez-Sevilla; Miguel Quintana-Quintana; Norberto García-García; Rolando Hernández-Muñoz
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  Humanin: a mitochondrial signaling peptide as a biomarker for impaired fasting glucose-related oxidative stress.

Authors:  Annet Voigt; Herbert F Jelinek
Journal:  Physiol Rep       Date:  2016-05

9.  Decrease of Plasma Glucose by Hibiscus taiwanensis in Type-1-Like Diabetic Rats.

Authors:  Lin-Yu Wang; Hsien-Hui Chung; Juei-Tang Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

Review 10.  Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.

Authors:  Giovanni Pagano; Annarita Aiello Talamanca; Giuseppe Castello; Mario D Cordero; Marco d'Ischia; Maria Nicola Gadaleta; Federico V Pallardó; Sandra Petrović; Luca Tiano; Adriana Zatterale
Journal:  Oxid Med Cell Longev       Date:  2014-05-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.